1. Home
  2. FICO vs RVPH Comparison

FICO vs RVPH Comparison

Compare FICO & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FICO
  • RVPH
  • Stock Information
  • Founded
  • FICO 1956
  • RVPH 2006
  • Country
  • FICO United States
  • RVPH United States
  • Employees
  • FICO N/A
  • RVPH N/A
  • Industry
  • FICO Business Services
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FICO Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • FICO Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • FICO 44.5B
  • RVPH 32.8M
  • IPO Year
  • FICO 1987
  • RVPH N/A
  • Fundamental
  • Price
  • FICO $1,505.39
  • RVPH $0.39
  • Analyst Decision
  • FICO Buy
  • RVPH Strong Buy
  • Analyst Count
  • FICO 12
  • RVPH 5
  • Target Price
  • FICO $2,228.00
  • RVPH $9.00
  • AVG Volume (30 Days)
  • FICO 341.1K
  • RVPH 3.7M
  • Earning Date
  • FICO 07-30-2025
  • RVPH 08-13-2025
  • Dividend Yield
  • FICO N/A
  • RVPH N/A
  • EPS Growth
  • FICO 21.78
  • RVPH N/A
  • EPS
  • FICO 23.21
  • RVPH N/A
  • Revenue
  • FICO $1,840,361,000.00
  • RVPH N/A
  • Revenue This Year
  • FICO $17.67
  • RVPH N/A
  • Revenue Next Year
  • FICO $15.78
  • RVPH N/A
  • P/E Ratio
  • FICO $64.84
  • RVPH N/A
  • Revenue Growth
  • FICO 14.71
  • RVPH N/A
  • 52 Week Low
  • FICO $1,484.29
  • RVPH $0.30
  • 52 Week High
  • FICO $2,402.52
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • FICO 27.12
  • RVPH 35.22
  • Support Level
  • FICO $1,520.00
  • RVPH $0.38
  • Resistance Level
  • FICO $1,905.33
  • RVPH $0.45
  • Average True Range (ATR)
  • FICO 90.85
  • RVPH 0.05
  • MACD
  • FICO -33.97
  • RVPH 0.01
  • Stochastic Oscillator
  • FICO 6.10
  • RVPH 17.57

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: